Search results
Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management...
Motley Fool via Yahoo Finance· 3 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment, and...
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The...
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
Motley Fool· 5 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has built a billion-dollar cystic fibrosis (CF) treatment...
Is Vertex Pharmaceuticals a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has beaten the bear market by far this year: The stock is heading for a 30% gain. Vertex is the global leader in...
Is Vertex Pharmaceuticals Stock a Buy Now?
Motley Fool via Yahoo Finance· 3 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has been one of the hottest growth stocks to own within the healthcare industry. The company has a dominant cystic...
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market....
Vertex Pharmaceuticals Stock Gets Technical Rating Upgrade
Investor's Business Daily· 1 year agoVertex Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on...
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 5 months agoSometimes a company has a mixture of proven performance and upcoming catalysts that make the idea of...
Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It
Investor's Business Daily· 1 month agoAnalysts applauded Vertex Pharmaceuticals on Thursday for its acquisition of Alpine Immune Sciences...
Is Vertex Pharmaceuticals About to Become a Dividend Stock?
Motley Fool· 2 years agoVertex Pharmaceuticals (NASDAQ: VRTX) announced stellar third-quarter results last week. The...
